488 related articles for article (PubMed ID: 22413108)
1. Positron emission tomography in the prediction of inflammation in children with human immunodeficiency virus related bronchiectasis.
Masekela R; Gongxeka H; Green RJ; Sathekge M
Hell J Nucl Med; 2012; 15(1):23-7. PubMed ID: 22413108
[TBL] [Abstract][Full Text] [Related]
2. Immune reconstitution inflammatory syndrome due to Mycobacterium avium complex successfully followed up using 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a patient with human immunodeficiency virus infection: A case report.
Namkoong H; Fujiwara H; Ishii M; Yagi K; Haraguchi M; Matsusaka M; Suzuki S; Asakura T; Asami T; Saito F; Fukunaga K; Tasaka S; Betsuyaku T; Hasegawa N
BMC Med Imaging; 2015 Jul; 15():24. PubMed ID: 26187282
[TBL] [Abstract][Full Text] [Related]
3. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.
Martin C; Castaigne C; Tondeur M; Flamen P; De Wit S
HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190
[TBL] [Abstract][Full Text] [Related]
4.
Bouter C; Braune I; Meller B; Sahlmann C; Ritter C; Meller J
Nuklearmedizin; 2016 Dec; 55(6):242-249. PubMed ID: 27617327
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.
Balink H; Veeger NJ; Bennink RJ; Slart RH; Holleman F; van Eck-Smit BL; Verberne HJ
Nucl Med Commun; 2015 Jun; 36(6):604-9. PubMed ID: 25738560
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET/CT in the diagnosis of fever of unknown origin.
Balink H; Collins J; Bruyn GA; Gemmel F
Clin Nucl Med; 2009 Dec; 34(12):862-8. PubMed ID: 20139818
[TBL] [Abstract][Full Text] [Related]
7. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.
Lee KH; Cho A; Choi YJ; Lee SW; Ha YJ; Jung SJ; Park MC; Lee JD; Lee SK; Park YB
Arthritis Rheum; 2012 Mar; 64(3):866-75. PubMed ID: 21989701
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET imaging in HIV infection and tuberculosis.
Sathekge M; Maes A; Van de Wiele C
Semin Nucl Med; 2013 Sep; 43(5):349-66. PubMed ID: 23905617
[TBL] [Abstract][Full Text] [Related]
9. HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): a prospective cross-sectional study.
Knudsen A; Hag AM; Loft A; von Benzon E; Keller SH; Møller HJ; Lebech AM; Ripa RS; Kjær A
J Nucl Cardiol; 2015 Apr; 22(2):372-80. PubMed ID: 25467249
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
Sun XG; Huang G; Liu JJ; Wan LR
Hell J Nucl Med; 2009; 12(2):115-8. PubMed ID: 19675862
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT.
Amin R; Charron M; Grinblat L; Shammas A; Grasemann H; Graniel K; Ciet P; Tiddens H; Ratjen F
Radiology; 2012 Sep; 264(3):868-75. PubMed ID: 22829680
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
14. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
[TBL] [Abstract][Full Text] [Related]
15. Imaging infection and inflammation in children with (18)F-FDG PET and (18)F-FDG PET/CT.
Servaes S
J Nucl Med Technol; 2011 Sep; 39(3):179-82. PubMed ID: 21795366
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
Zhang TM; Zhang LM; Liu Y; Zhang ZF; Wang CL
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2901-4. PubMed ID: 23328236
[TBL] [Abstract][Full Text] [Related]
17. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
18. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
19. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
20. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
